Abstract is: Frank C. Odds was an English mycologist. He studied Candida albicans, establishing how modern researchers study fungal pathogens and the diseases they cause.
| human | Q5 |
| P428 | botanist author abbreviation | Odds |
| P269 | IdRef ID | 113079869 |
| P586 | IPNI author ID | 20036611-1 |
| P213 | ISNI | 0000000084174542 |
| P244 | Library of Congress authority ID | n78061709 |
| P8189 | National Library of Israel J9U ID | 987007454877205171 |
| P691 | NL CR AUT ID | xx0182576 |
| P1153 | Scopus author ID | 7005467384 |
| P214 | VIAF ID | 3735297 |
| P108 | employer | University of Aberdeen | Q270532 |
| P101 | field of work | biochemistry | Q7094 |
| bacteriology | Q243748 | ||
| medical mycology | Q1916567 | ||
| P735 | given name | Frank | Q220546 |
| Frank | Q220546 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | botanist | Q2374149 |
| university teacher | Q1622272 | ||
| biochemist | Q2919046 | ||
| bacteriologist | Q15816836 | ||
| P21 | sex or gender | male | Q6581097 |
| Q50507878 | "Room temperature" use of CHROMagar Candida. |
| Q52515776 | A morphology index for characterization of cell shape in Candida albicans. |
| Q33782528 | A multifunctional mannosyltransferase family in Candida albicans determines cell wall mannan structure and host-fungus interactions. |
| Q67261456 | A simple system for the presumptive identification of Candida albicans and differentiation of strains within the species |
| Q48901849 | Academic selection criteria and subsequent performance |
| Q50725227 | Acid phosphatase levels in the genus Candida and their application to the taxonomy and identification of pathogenic Candida species. |
| Q69923188 | Adherence of Candida albicans to vaginal epithelia: significance of morphological form and effect of ketoconazole |
| Q43722047 | An Examination of the Production of Hydrolytic Enzymes and Toxins by Pathogenic Strains of Candida albicans |
| Q37781273 | An insight into the antifungal pipeline: selected new molecules and beyond. |
| Q37258061 | Analysis of Candida albicans phenotypes from different geographical and anatomical sources. |
| Q35629652 | Animal models of mucosal Candida infection |
| Q45240157 | Antifungal agent resistance of yeasts of clinical significance |
| Q34208354 | Antifungal agents: mechanisms of action |
| Q80308369 | Antifungal combinations: where do we stand? |
| Q43889167 | Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro |
| Q39881200 | Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents |
| Q35118435 | Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation |
| Q45020756 | Arthritis without grains caused by Pseudallescheria boydii |
| Q46885952 | Azole antifungals induce up-regulation of SAP4, SAP5 and SAP6 secreted proteinase genes in filamentous Candida albicans cells in vitro and in vivo. |
| Q70267249 | Binding of plasma proteins to Candida species in vitro |
| Q39844871 | Biotyping of medically important fungi |
| Q34327523 | CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. |
| Q35913482 | Candida albicans Iff11, a secreted protein required for cell wall structure and virulence |
| Q46447946 | Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulence. |
| Q42100410 | Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro |
| Q24805003 | Candida albicans genome sequence: a platform for genomics in the absence of genetics |
| Q69932721 | Candida albicans proteinase as a virulence factor in the pathogenesis of Candida infections |
| Q44080387 | Candida albicans strain types from the genitalia of patients with and without Candida infection |
| Q72170506 | Candida albicans, the life and times of a pathogenic yeast |
| Q84757332 | Candida albicans: fundamental research on an opportunistic human pathogen |
| Q40012914 | Candida and Torulopsis: a blinded evaluation of use of pseudohypha formation as basis for identification of medically important yeasts |
| Q68050010 | Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis |
| Q37064303 | Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation |
| Q34174059 | Candida infections: an overview |
| Q33210615 | Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. |
| Q69503730 | Candida species and C. albicans biotypes in women attending clinics in genitourinary medicine |
| Q36538932 | Carnitine-dependent transport of acetyl coenzyme A in Candida albicans is essential for growth on nonfermentable carbon sources and contributes to biofilm formation |
| Q41787001 | Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa. |
| Q40088759 | Characterization of an azole-resistant Candida glabrata isolate |
| Q46818343 | Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. |
| Q30451715 | Collaborative investigation of variables in susceptibility testing of yeasts |
| Q63975860 | Comparison of Candida albicans strain types among isolates from three countries |
| Q68917888 | Consistency of protein patterns in Candida albicans during hyphal septum and branch formation |
| Q47917035 | Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans |
| Q41820470 | Control of an outbreak of systemic Candida albicans |
| Q43126964 | Correction for Sandai et al., The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans |
| Q45754097 | Cross-sectional study of oral Candida carriage in a human immunodeficiency virus (HIV)-seropositive population: predisposing factors, epidemiology and antifungal susceptibility |
| Q34982359 | Cure and Relapse with Antifungal Therapy |
| Q70410860 | Demonstration of a septal pore in budding Candida albicans yeast cells |
| Q68182636 | Development of Candida albicans hyphae in different growth media--variations in growth rates, cell dimensions and timing of morphogenetic events |
| Q36855581 | Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te |
| Q30479432 | Developmental regulation of an adhesin gene during cellular morphogenesis in the fungal pathogen Candida albicans. |
| Q35073747 | Different consequences of ACE2 and SWI5 gene disruptions for virulence of pathogenic and nonpathogenic yeasts |
| Q34484827 | Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants |
| Q68155963 | Disseminated Candida infection syndrome in heroin addicts--dominance of a single Candida albicans biotype |
| Q33848251 | Distribution of pathogenic yeasts and humoral antibodies to candida among hospital inpatients |
| Q63975842 | Does Candida Albicans play a role in the etiology of endometriosis? |
| Q36586699 | Drug evaluation: BAL-8557--a novel broad-spectrum triazole antifungal. |
| Q33488522 | Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections |
| Q40188604 | Ecology and epidemiology of Candida species. |
| Q37226653 | Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus |
| Q44440963 | Editorial Commentary: Fluconazole Plus Amphotericin B Combinations Are Not Contraindicated and May Add Benefit for the Treatment of Candidemia |
| Q82306025 | Editorial: Resistance to antifungal agents |
| Q54530696 | Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections. |
| Q70110331 | Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae |
| Q43475264 | Effects of itraconazole on phagocytosis and killing of Candida glabrata by polymorphonuclear leucocytes from guinea pigs |
| Q35811074 | Effects of temperature on anti-Candida activities of antifungal antibiotics |
| Q42286250 | Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. |
| Q44088886 | Efficacy of parenteral itraconazole against disseminated Candida albicans infection in two mouse strains. |
| Q35666505 | Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo |
| Q36313772 | Endoplasmic reticulum alpha-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host-fungus interaction |
| Q53987962 | Enzyme activities associated with carbohydrate synthesis and breakdown in the yeast and mycelial forms of Candida albicans. |
| Q40950104 | Epidemiological shifts in opportunistic and nosocomial Candida infections: mycological aspects |
| Q51152330 | Expansion of the Candida albicans cell envelope in different morphological forms of the fungus. |
| Q46430351 | Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes |
| Q67673027 | Expression of an epitope by surface glycoproteins of Candida albicans. Variability among species, strains and yeast cells of the genus Candida |
| Q46738328 | Functional analysis of the phospholipase C gene CaPLC1 and two unusual phospholipase C genes, CaPLC2 and CaPLC3, of Candida albicans |
| Q34772194 | Fungal morphogenesis and host invasion |
| Q40522408 | GFP as a quantitative reporter of gene regulation in Candida albicans. |
| Q33768787 | Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection |
| Q44349133 | Genetic evidence for recombination in Candida albicans based on haplotype analysis |
| Q34888535 | Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney. |
| Q36405503 | Genomics, molecular targets and the discovery of antifungal drugs |
| Q41823869 | Global role of the protein kinase Gcn2 in the human pathogen Candida albicans. |
| Q42636549 | Glucose promotes stress resistance in the fungal pathogen Candida albicans. |
| Q35059329 | Glycosylation status of the C. albicans cell wall affects the efficiency of neutrophil phagocytosis and killing but not cytokine signaling. |
| Q46790340 | Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions |
| Q52939255 | Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. |
| Q70337607 | Growth of pathogenic Candida isolates anaerobically and under elevated concentrations of CO2 in air |
| Q44286557 | Identification, cloning and characterization of the gene for the secretory aspartate protease of Candida albicans |
| Q43163022 | Immune recognition of Candida albicans beta-glucan by dectin-1. |
| Q34619615 | Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors |
| Q43419655 | Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions |
| Q43267952 | In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade 1. |
| Q35551843 | Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis |
| Q72149575 | Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis |
| Q36914013 | Infection-related gene expression in Candida albicans |
| Q44088882 | Influence of grapefruit juice on itraconazole plasma levels in mice and guinea pigs. |
| Q42129126 | Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro |
| Q70214056 | Interactions of Candida albicans Yeast Cells, Germ Tubes and Hyphae with Human Polymorphonuclear Leucocytes in vitro |
| Q37157546 | Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species |
| Q40857041 | Intraconazole--a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses |
| Q35137446 | Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes |
| Q67888134 | Long-term laboratory preservation of pathogenic yeasts in water |
| Q40532174 | Loss of cell wall mannosylphosphate in Candida albicans does not influence macrophage recognition |
| Q35604809 | MAPKKK-independent regulation of the Hog1 stress-activated protein kinase in Candida albicans |
| Q40509538 | Mechanisms and clinical impact of antifungal drug resistance. |
| Q42091341 | Melanin externalization in Candida albicans depends on cell wall chitin structures |
| Q33818873 | Might Candida albicans be made to mate after all? |
| Q63975863 | Mitochondrial haplotypes and recombination inCandida albicans |
| Q37154342 | Mixed Candida albicans strain populations in colonized and infected mucosal tissues |
| Q37109793 | Mnt1p and Mnt2p of Candida albicans are partially redundant alpha-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence. |
| Q70253755 | Modification and extension of tests for differentiation ofCandidaspecies and strains |
| Q35138586 | Molecular biological characterization of an azole-resistant Candida glabrata isolate |
| Q40589073 | Molecular mechanisms of drug resistance in fungi |
| Q63975865 | Molecular phylogenetic analysis of Candida tropicalis isolates by multi-locus sequence typing |
| Q37658660 | Molecular phylogenetics and epidemiology of Candida albicans |
| Q35948286 | Molecular phylogenetics of Candida albicans. |
| Q39824540 | Morphogenesis in Candida albicans |
| Q36542562 | Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi |
| Q46545565 | Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea |
| Q34719660 | Multilocus sequence typing for analyses of clonality of Candida albicans strains in Taiwan |
| Q34143824 | Multilocus sequence typing for differentiation of strains of Candida tropicalis |
| Q57907199 | Multilocus sequence typing of Candida albicans isolates from animals |
| Q37154596 | Multilocus sequence typing of pathogenic Candida species |
| Q52577896 | Multiple functions of DOA1 in Candida albicans. |
| Q36534987 | Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates. |
| Q34499832 | Mycology in oral pathology |
| Q34081697 | NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans |
| Q37625016 | Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection. |
| Q35190223 | New Clox Systems for rapid and efficient gene disruption in Candida albicans. |
| Q35783942 | Niche-specific activation of the oxidative stress response by the pathogenic fungus Candida albicans. |
| Q34651681 | Niche-specific regulation of central metabolic pathways in a fungal pathogen. |
| Q41046836 | Nomenclature of fungal diseases |
| Q44820687 | Nomenclature of fungal diseases: a report and recommendations from a Sub-Committee of the International Society for Human and Animal Mycology (ISHAM). |
| Q54309140 | Non-identity and authentication of two major reference strains ofCandida albicans |
| Q43454890 | Numerical taxonomic analysis of imperfect yeast species in Candida and Torulopsis shows no basis for generic separation |
| Q33910250 | One year prospective survey of Candida bloodstream infections in Scotland. |
| Q39848591 | Optimization and validation of multilocus sequence typing for Candida albicans. |
| Q40308282 | Optimum conditions for initiation of filamentation in Candida albicans |
| Q52566975 | Outer chain N-glycans are required for cell wall integrity and virulence of Candida albicans. |
| Q36521041 | Oxygen as limiting nutrient for growth of Cryptococcus neoformans |
| Q40697947 | Pathogenesis of Candida infections |
| Q46888040 | Pathogenesis of invasive candidiasis |
| Q39254313 | Peptones and mycological reproducibility |
| Q35216691 | Peroxisomal fatty acid beta-oxidation is not essential for virulence of Candida albicans. |
| Q54288714 | Personal opinion: Can antifungal sensitivity tests predict clinical treatment outcomes? |
| Q34143749 | Population structure and properties of Candida albicans, as determined by multilocus sequence typing |
| Q45207479 | Predominance of Candida albicans serotype A, biotype 15 3/7 in outbreaks of disseminated candidiasis in heroin addicts in Spain |
| Q33846571 | Prevalence of pathogenic yeasts and humoral antibodies to candida in diabetic patients |
| Q36715900 | Problems in the laboratory assessment of antifungal activity |
| Q48659157 | Professor Emly Glyn Vaughan Evans 4th October 1941-4th August 2003. |
| Q37122002 | Property differences among the four major Candida albicans strain clades |
| Q40120578 | Purification and Properties of a Glycoprotein Acid Phosphatase from Candida albicans |
| Q37256349 | Pyrosequencing analysis of 20 nucleotides of internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis |
| Q36529693 | Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole |
| Q40214454 | Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts |
| Q67783566 | Reaction of Candida albicans cells of different morphology index with monoclonal antibodies specific for the hyphal form |
| Q42727068 | Recognition and blocking of innate immunity cells by Candida albicans chitin |
| Q77909019 | Reduction in the growth of non-dermatophyte moulds by itraconazole: evaluation by corneofungimetry assay |
| Q42798267 | Reporters for the analysis of N-glycosylation in Candida albicans. |
| Q34569070 | Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences |
| Q40950101 | Resistance of clinically important yeasts to antifungal agents |
| Q40339776 | Resistance of the Candida albicans filamentous cycle to environmental change |
| Q40918799 | Resistance of yeasts to azole-derivative antifungals |
| Q37164067 | Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ |
| Q34865666 | Role of the Candida albicans MNN1 gene family in cell wall structure and virulence. |
| Q40339324 | Routine use of modified Sabouraud's dextrose broth in the germ tube test for Candida albicans |
| Q37043290 | Sabouraud('s) agar |
| Q79716339 | Secreted proteinases and Candida albicans virulence |
| Q42623037 | Sequence of the Candida albicans gene encoding the secretory aspartate proteinase |
| Q40271712 | Should resistance to azole antifungals in vitro be interpreted as predicting clinical non-response? |
| Q46322603 | Single allele knock-out of Candida albicans CGT1 leads to unexpected resistance to hygromycin B and elevated temperature |
| Q52500266 | Standardization of antigens from Aspergillus fumigatus |
| Q41819710 | Strain typing and determination of population structure of Candida krusei by multilocus sequence typing. |
| Q54440264 | Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents. |
| Q46611821 | Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host |
| Q35122897 | Susceptibilities of Candida spp. to antifungal agents visualized by two-dimensional scatterplots of relative growth |
| Q43693090 | Susceptibility testing of pathogenic fungi with itraconazole: a process analysis of test variables |
| Q73521098 | Synergy, antagonism, and what the chequerboard puts between them |
| Q43105019 | Synthesis and in vitro and in vivo antifungal activity of the hydroxy metabolites of saperconazole |
| Q46383166 | Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology |
| Q44969751 | Systemic candidiasis in Spanish heroin addicts: a possible source of infection |
| Q40429211 | Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. |
| Q38338874 | The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence |
| Q33205415 | The Candida albicans pH-regulated KER1 gene encodes a lysine/glutamic-acid-rich plasma-membrane protein that is involved in cell aggregation |
| Q34697820 | The Mnn2 mannosyltransferase family modulates mannoprotein fibril length, immune recognition and virulence of Candida albicans |
| Q53967268 | The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole |
| Q44029281 | The effect of growth medium of filament production in Candida albicans |
| Q36460850 | The evolutionary rewiring of ubiquitination targets has reprogrammed the regulation of carbon assimilation in the pathogenic yeast Candida albicans. |
| Q37489316 | The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis |
| Q35639464 | Typing of Candida albicans strains |
| Q70251748 | Virulence For Mice Of A Proteinase-Secreting Strain Of Candida Albicans And A Proteinase-Deficient Mutant |
| Q54160281 | [Changes in epidemiology of opportunistic infections due to Candida] |
| Q68217519 | [Recent advances in the biology of Candida] |
| Q69559250 | [Relative inhibition factors: a new approach to the evaluation of antifungal antibiotics in vitro] |
| Frank Odds | wikipedia |
Search more.